e.mwangi

TL2 · Bursa

Contributes reviews on supplier material. Based in Bursa.

Joined 6 January 2025 · last posted 5d

77 posts, newest first. Showing up to 150.

Follow-up: Sleep quality changes during weight loss Replied, post #77 · Wellbeing › Sleep · 23 Jul 2026 · 7 likes Reflux at night follows directly from delayed gastric emptying and is a mechanical explanation for a complaint often attributed elsewhere. That is my reading. Someone…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #41 · Compounds › Retatrutide · 20 Jul 2026 · 7 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #12 · Clinical › Bloodwork · 18 Jul 2026 · 1 like Quietly grateful for the plain phrasing. Not every thread gets that.
Here for the analytics and not much else Replied, post #39 · Lounge › Introductions · 15 Jul 2026 · 26 likes Good to have another set of eyes on the wiki posts. Community wiki editing is open at trust level three and the queue of small corrections is permanently longer than…
I joined for one answer and stayed for a year — what changed my mind Replied, post #67 · Start Here › Welcome · 7 Jul 2026 · 3 likes One thing that took me a while to notice: the search box indexes maintained documents as well as topics, and documents carry a review date. If a document and a…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #55 · Analytics › Home & field testing · 5 Jul 2026 · 10 likes Confirming post #54 from a second method, which matters more than confirming it from a second person. Ultraviolet absorbance at 280 nanometres estimates concentration…
Coming back to: Telehealth prescribing models in the US Replied, post #5 · Regional › North America · 4 Jul 2026 · 2 likes I read the earlier replies on Telehealth prescribing models twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with…
What to include when your question involves a laboratory result Replied, post #10 · Start Here › How to Ask · 1 Jul 2026 · 6 likes Worth separating two things that post #9 runs together. Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how…
Revisiting: What pooling buys you and what it destroys Replied, post #50 · Evidence › Meta-analyses · 10 Jun 2026 · 11 likes Noted, and thank you for writing it out rather than summarising it.
Search filters: what is missing Replied, post #57 · Meta › Site feedback · 14 May 2026 · 14 likes Confirming post #56 from a second method, which matters more than confirming it from a second person. Search and findability: if you searched for something and did not…
Official shortage notices and what they authorise Replied, post #47 · Access › Shortages · 13 May 2026 · 0 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #31 · Safety › Contraindications · 7 May 2026 · 0 likes Where labelling has changed, the change is dated and public, and citing the current version is the whole of the discipline. I have said this before in a thread nobody…
Request declined, with reasoning — what changed since Replied, post #27 · Meta › Feature requests · 6 Apr 2026 · 0 likes Request declined is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #7 · Compounds › Repair & healing peptides · 3 Apr 2026 · 0 likes Narrowing post #4, because the general version has more than one answer. Stability of BPC-157 in solution: what has been measured in published work covers specific…
Grapefruit: why this class is not the class that cares Replied, post #97 · Practice › Interactions · 30 Mar 2026 · 5 likes Having read the whole grapefruit thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #28 · Sourcing › Logistics · 28 Mar 2026 · 0 likes This follows post #25 rather than contradicting it. I would rather this thread reach "we do not know" about Regional warehouse stock versus direct than reach a…
Transporting a vial for a weekend away — a second dataset Replied, post #11 · Practice › Storage & stability · 21 Mar 2026 · 1 like Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #23 · Compounds › Repair & healing peptides · 17 Mar 2026 · 33 likes Answering the Stability of BPC-157 question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the…
Realistic expectations for strength while losing weight quickly Replied, post #71 · Nutrition & Training › Resistance training · 14 Mar 2026 · 3 likes Coming back to post #67, because the follow-up matters more than the original answer. Reduced appetite makes fuelling a session harder, and that is a practical problem…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #54 · Research Methods › N-of-1 designs · 11 Mar 2026 · 4 likes ABAB design has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
Blinding yourself: practical methods and their limits Replied, post #9 · Research Methods › N-of-1 designs · 6 Mar 2026 · 16 likes This follows post #6 rather than contradicting it. Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures…
Second pass at: What to keep a record of at the point of payment Replied, post #15 · Sourcing › Payments · 2 Mar 2026 · 19 likes Right, and stated more narrowly than I would have dared to state it.
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #83 · Outcomes › Progress reports · 18 Feb 2026 · 1 like Narrowing post #82, because the general version has more than one answer. Self-reported intake is optimistic in a consistent direction, and saying so in your own report…
Revisiting: Absolute versus relative contraindications Replied, post #26 · Safety › Contraindications · 16 Feb 2026 · 4 likes Picking up post #23: that is the part I would want checked first. Somebody's condition being on a list does not settle the decision, and somebody's condition being…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #84 · Pharmacology › Pharmacokinetics · 15 Feb 2026 · 0 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability. I am aware this is the third…
Forced degradation studies: designing one that is informative Replied, post #3 · Analytics › Method validation · 4 Feb 2026 · 0 likes The opening post is right about the mechanism and I think understates the practical bit. Range and working range are different things and a certificate rarely…
A supplier who responds to a discrepancy with silence — what changed since Started this topic · Sourcing › Red flags · 26 Jan 2026 · 12 likes A supplier who responds to a discrepancy with silence — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #66 · Practice › Side effects · 10 Jan 2026 · 23 likes Confirming post #65 from a second method, which matters more than confirming it from a second person. The relationship between symptom burden and outcome is not what…
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #22 · Compounds › Retatrutide · 26 Dec 2025 · 1 like Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #42 · Documentation › Doc review · 23 Dec 2025 · 0 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice. For what it is worth, the…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #18 · Clinical › Bloodwork · 2 Dec 2025 · 26 likes Adding a null result on reference intervals. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Pen dose counters: what a click does and does not guarantee Replied, post #84 · Devices › Pens & autoinjectors · 18 Nov 2025 · 0 likes A pen that has been dropped may not be visibly damaged and may not deliver accurately afterwards. Manufacturers say to replace rather than to test, and there is no test…
What a confidence interval means, from scratch — the long version Replied, post #12 · Research Methods › Statistics · 31 Oct 2025 · 1 like Post #10 put the caveat in the right place and I want to underline it. Confidence interval sits at the boundary between what this community can usefully discuss and…
Insurance and replacement policies, compared — the long version Replied, post #33 · Sourcing › Logistics · 30 Oct 2025 · 0 likes Post #30 is the version of this I will quote in future. One addition. I have no financial interest in anything named in this thread and I want to say so before I…
Stepping down deliberately, and how to do it without losing progress Replied, post #5 · Practice › Dosing & titration · 18 Oct 2025 · 4 likes I read post #3 twice before replying, because I had assumed the opposite. Dose and effect are not linear across the studied range for every compound in this class.…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #25 · Compounds › Semaglutide · 17 Oct 2025 · 0 likes Everything in post #23 holds. The case it does not cover is the one I have. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology…
Can a home kit substitute for a laboratory report? A careful no Replied, post #24 · Analytics › Home & field testing · 5 Oct 2025 · 16 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #16 · Compounds › Semaglutide · 26 Sep 2025 · 1 like Answering the question post #14 raises rather than the one it answers. Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #124 · Data & Tools › Calculators · 21 Sep 2025 · 6 likes Everything in post #122 holds. The case it does not cover is the one I have. A titration planner is a scheduling aid rather than a clinical recommendation, and any tool…
Follow-up: Why appetite effects are mostly central Replied, post #45 · Pharmacology › Receptor biology · 19 Sep 2025 · 11 likes Understood, and I withdraw the assumption I opened with.
Warfarin and altered intake: the monitoring argument — the long version Replied, post #18 · Practice › Interactions · 17 Sep 2025 · 5 likes Building on post #17 rather than restating it. Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #46 · Practice › Side effects · 8 Sep 2025 · 2 likes Careful with the language on nausea timeline. "Not detected" and "not present" are different findings and the first is a statement about the method.
When a preprint is the best available evidence and we say so Replied, post #120 · Evidence › Preprints · 31 Aug 2025 · 1 like Understood. Thank you for being specific about the limits of it.
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #15 · Evidence › Preprints · 15 Aug 2025 · 28 likes Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can be genuinely useful. For what it is worth, the…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #86 · Compounds › Repair & healing peptides · 31 Jul 2025 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
About the Trials category Replied, post #5 · Evidence › Trials · 16 Jul 2025 · 21 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #24 · Devices › Pens & autoinjectors · 13 Jul 2025 · 19 likes Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you have the correct pen before injection prevents administration…
Journal club: SURMOUNT-1, read without the press release Replied, post #150 · Evidence › Journal club · 2 Jul 2025 · 3 likes Post #146 and I disagree about the size of the effect, not about the direction. A note on how SURMOUNT-1 gets discussed rather than on SURMOUNT-1 itself: the confident…
Reading an MS report that only gives you a single number Replied, post #102 · Analytics › Mass spectrometry · 8 Jun 2025 · 28 likes Taking post #99 at face value and following it one step further. An acylated peptide has a mass that reflects the modification, so comparing against the mass of the…
[2026 update] An appeal that failed, and what I would do differently Replied, post #16 · Access › Insurance & coverage · 7 Jun 2025 · 13 likes My position on appeal is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Why the timeline is on the right and not the left Replied, post #23 · Meta › Site feedback · 30 May 2025 · 9 likes Building on post #21 rather than restating it. Something worth flagging about timeline: the strongest-sounding claims in this thread are the ones with no source…
Reading a trial's population section before its results — does this still hold? Replied, post #130 · Evidence › Trials · 21 May 2025 · 32 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
What a 2 ppm match establishes, and what it does not Replied, post #19 · Analytics › Mass spectrometry · 19 May 2025 · 28 likes I had written a reply contradicting post #17 and deleted it. Here is what survived. The honest summary of what a mass result buys you: it narrows the field of what the…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #118 · Compounds › Semaglutide · 15 May 2025 · 6 likes For anyone finding this later: the short answer on SELECT is that it depends on one thing, and the rest of the thread is people identifying which thing.
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #29 · Compounds › Oral incretins · 9 May 2025 · 31 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Follow-up: Documentation that appears only after payment Replied, post #44 · Sourcing › Red flags · 4 May 2025 · 31 likes Post #43 describes the usual case. This is about the unusual one. The strongest single signal available cheaply is what happens when you ask a technical question. A…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #29 · Evidence › Journal club · 25 Apr 2025 · 28 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
Talking to a therapist about this specifically — does this still hold? Replied, post #50 · Wellbeing › Mental health · 24 Apr 2025 · 30 likes The arithmetic in post #48 is right; the assumption feeding it is the part to check. Motivation and expectation: starting with clear motivation and realistic…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #125 · Sourcing › Regulatory · 10 Apr 2025 · 0 likes I read post #123 twice before replying, because I had assumed the opposite. Nothing in this subcategory is legal advice, and the members who work in regulated…
A well-designed study with a badly written abstract Replied, post #15 · Evidence › Study critique · 8 Apr 2025 · 9 likes A criticism that would apply equally to every trial in the field is worth stating once and is not a reason to discount a particular paper.
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #138 · Access › International · 1 Apr 2025 · 5 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
Why cagrilintide alone is discussed so much less than in combination Replied, post #36 · Compounds › Cagrilintide & amylin analogues · 26 Mar 2025 · 3 likes Anyone reading a purity result for cagrilintide should know that its aggregation behaviour makes sample handling matter more than usual. A result on a sample that was…
Coverage for the indication versus for the drug — a second dataset Replied, post #20 · Access › Insurance & coverage · 15 Mar 2025 · 24 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #22 · Sourcing › Regulatory · 28 Feb 2025 · 22 likes A compound in a compounding pathway in one country and unavailable in another is a common situation and produces most of the confusion here.
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #36 · Documentation › Doc review · 14 Feb 2025 · 6 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage.
Second pass at: Regression to the mean in progress reports Replied, post #47 · Research Methods › Statistics · 6 Feb 2025 · 0 likes My position on Regression is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #27 · Evidence › Meta-analyses · 1 Feb 2025 · 2 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #64 · Data & Tools › Calculators · 25 Jan 2025 · 6 likes The reconstitution calculation is total mass divided by total volume for concentration, then dose divided by concentration for volume, then volume times one hundred for…
Recovery when intake is low: what to cut first Replied, post #76 · Nutrition & Training › Resistance training · 14 Jan 2025 · 13 likes Everything in post #75 holds. The case it does not cover is the one I have. Nothing here is medical advice and anybody with a relevant condition should have a programme…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #30 · Clinical › Special populations · 22 Nov 2024 · 6 likes Nothing in this subcategory is medical advice and the questions asked here are precisely the ones that need an individual assessment. I have seen it go both ways, which…
Time to steady state after a dose increase Replied, post #35 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 9 likes Between-person variability in exposure is substantial and is the reason two people on the same dose can have quite different plasma concentrations. That is inherent…
Identical chromatograms across two different lots Replied, post #41 · Sourcing › Red flags · 25 Oct 2024 · 0 likes I read post #39 twice before replying, because I had assumed the opposite. One caution on identical chromatograms: everything above assumes the underlying documentation…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #113 · Sourcing › Independent verification · 6 Oct 2024 · 8 likes What I would tell a new member reading about Splitting a vial for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #4 · Clinical › Comorbidities · 26 Sep 2024 · 0 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. Second-hand on Type 2 diabetes, so weight it accordingly — someone whose…
About the Protein & intake category Replied, post #7 · Nutrition & Training › Protein & intake · 17 Sep 2024 · 25 likes Building on post #4 rather than restating it. Fibre and fluid tend to fall alongside protein when intake drops, and the constipation reported here follows from that as…
The mass-error checker and its intended scope Replied, post #137 · Data & Tools › Calculators · 19 Jul 2024 · 4 likes What I would want before treating mass-error checker as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #43 · Practice › Dosing & titration · 7 Jul 2024 · 1 like Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…